Back

Paternal inheritance of a vulnerable opioid-taking phenotype in female rats

Chen, H.; Leng, S.; Khanam, S.; Mulligan, M. K.; Redei, E. E.

2026-06-18 animal behavior and cognition
10.64898/2026.06.14.732174 bioRxiv
Show abstract

Risk for opioid use disorder (OUD) is substantially heritable, yet its genetic architecture remains only partly understood. This study examined oxycodone intake in two nearly isogenic rat strains, Wistar Kyoto More Immobile (WMI) and Less Immobile (WLI), and their reciprocal female F1 offspring. The parental strains differ in depression-like behavior and substance use vulnerability, with WMI rats consuming more oxycodone than WLI controls. Voluntary consumption was measured with an operant licking self-administration protocol that delivered 60 l drug per reward. Across four experimental stages, oxycodone concentrations increased from 0.025 to 0.1 mg/ml, and session durations increased from 1 to 4 hours. Female offspring showed a parent-of-origin effect. F1 females sired by WMI fathers (WLIxWMI) displayed accelerated escalation during the transition from 1-hour to 4-hour sessions in Stage 2 and consumed more oxycodone than reciprocal WMIxWLI females across expanded-access stages. This vulnerability was associated with increased licking during the drug-unavailable timeout period. In WMI and reciprocal WMIxWLI female, consumption was regulated by the drugs subjective value, as measured by lick microstructure, during Stages 1 and 2. This relationship was absent in WLIxWMI females during Stage 2. Together, these findings suggest that paternal WMI lineage is associated with a rapid transition to high oxycodone intake and cue-directed drug seeking, and identify a parent-of-origin effect that may contribute to female vulnerability to addiction.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Neuropharmacology
68 papers in training set
Top 0.1%
14.6%
2
Translational Psychiatry
260 papers in training set
Top 0.3%
11.5%
3
Psychopharmacology
69 papers in training set
Top 0.1%
8.6%
4
Neuropsychopharmacology
153 papers in training set
Top 0.5%
6.1%
5
Frontiers in Behavioral Neuroscience
49 papers in training set
Top 0.2%
4.2%
6
Scientific Reports
3612 papers in training set
Top 28%
3.9%
7
Behavioural Brain Research
77 papers in training set
Top 0.4%
3.9%
50% of probability mass above
8
Genes, Brain and Behavior
30 papers in training set
Top 0.1%
3.9%
9
Drug and Alcohol Dependence
41 papers in training set
Top 0.2%
3.3%
10
Addiction Biology
51 papers in training set
Top 0.3%
3.1%
11
Biological Psychiatry
137 papers in training set
Top 1%
2.4%
12
Progress in Neuro-Psychopharmacology and Biological Psychiatry
48 papers in training set
Top 0.3%
2.3%
13
European Neuropsychopharmacology
20 papers in training set
Top 0.1%
2.3%
14
PLOS ONE
5266 papers in training set
Top 44%
2.3%
15
Hormones and Behavior
45 papers in training set
Top 0.2%
1.7%
16
Behavioral Neuroscience
25 papers in training set
Top 0.2%
1.7%
17
International Journal of Neuropsychopharmacology
14 papers in training set
Top 0.2%
1.6%
18
eLife
5828 papers in training set
Top 53%
1.5%
19
Alcoholism: Clinical and Experimental Research
14 papers in training set
Top 0.1%
1.5%
20
Alcohol
18 papers in training set
Top 0.2%
1.5%
21
eneuro
439 papers in training set
Top 5%
1.5%
22
The Journal of Neuroscience
1025 papers in training set
Top 8%
1.3%
23
Molecular Psychiatry
282 papers in training set
Top 4%
1.3%
24
Psychoneuroendocrinology
36 papers in training set
Top 0.4%
1.1%
25
Behavior Genetics
17 papers in training set
Top 0.1%
1.0%
26
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.3%
0.8%
27
European Journal of Neuroscience
189 papers in training set
Top 4%
0.8%
28
Frontiers in Pharmacology
111 papers in training set
Top 3%
0.8%
29
Frontiers in Neuroscience
256 papers in training set
Top 8%
0.6%
30
Brain Sciences
55 papers in training set
Top 2%
0.6%